BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2180328)

  • 21. Heterogeneity of clinical response during placebo treatment.
    Quitkin FM; Rabkin JG; Stewart JW; McGrath PJ; Harrison W; Ross DC; Tricamo E; Fleiss J; Markowitz J; Klein DF
    Am J Psychiatry; 1991 Feb; 148(2):193-6. PubMed ID: 1987817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events.
    de Jonge P; Honig A; van Melle JP; Schene AH; Kuyper AM; Tulner D; Schins A; Ormel J;
    Am J Psychiatry; 2007 Sep; 164(9):1371-8. PubMed ID: 17728422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do maladaptive attitudes cause depression?
    Silverman JS; Silverman JA; Eardley DA
    Arch Gen Psychiatry; 1984 Jan; 41(1):28-30. PubMed ID: 6691782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of alprazolam and imipramine for treatment of outpatient depression.
    Overall JE; Biggs J; Jacobs M; Holden K
    J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression.
    Rabkin JG; McGrath PJ; Quitkin FM; Tricamo E; Stewart JW; Klein DF
    Am J Psychiatry; 1990 Dec; 147(12):1622-6. PubMed ID: 2244639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using a self-report depression scale to identify remission in depressed outpatients.
    Zimmerman M; Posternak MA; Chelminski I
    Am J Psychiatry; 2004 Oct; 161(10):1911-3. PubMed ID: 15465991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severity of depression and response to cognitive behavior therapy.
    Thase ME; Simons AD; Cahalane J; McGeary J; Harden T
    Am J Psychiatry; 1991 Jun; 148(6):784-9. PubMed ID: 2035722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of placebo responders and nonresponders in subgroups of depressive disorder.
    Bialik RJ; Ravindran AV; Bakish D; Lapierre YD
    J Psychiatry Neurosci; 1995 Jul; 20(4):265-70. PubMed ID: 7647079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients.
    Lineberry CG; Johnston JA; Raymond RN; Samara B; Feighner JP; Harto NE; Granacher RP; Weisler RH; Carman JS; Boyer WF
    J Clin Psychiatry; 1990 May; 51(5):194-9. PubMed ID: 2110559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different types of placebo response in patients receiving antidepressants.
    Quitkin FM; McGrath PJ; Rabkin JG; Stewart JW; Harrison W; Ross DC; Tricamo E; Fleiss J; Markowitz J; Klein DF
    Am J Psychiatry; 1991 Feb; 148(2):197-203. PubMed ID: 1987818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.
    Feighner JP; Merideth CH; Claghorn JL
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):47-51. PubMed ID: 6370974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adinazolam mesylate and placebo in depressed outpatients: a 6-week, double-blind comparison.
    Cohn JB; Pyke RE; Wilcox CS
    J Clin Psychiatry; 1988 Apr; 49(4):142-7. PubMed ID: 3281930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of clinical and psychological methods in estimating antidepressants efficacy in treatment of depression (preliminary report)].
    Puzyński S; Koszewska I; Habrat E; Fornal S; Bzinkowska D; Gradzka D; Kalinowski A; Swiecicki Ł; Torbiński J
    Psychiatr Pol; 2002; 36(2):225-38. PubMed ID: 12043041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amoxapine and imipramine: a double-blind study in depressed patients.
    Sathananthan GL; Matz R; Thompson H; Gershon S
    Curr Ther Res Clin Exp; 1973 Dec; 15(12):919-22. PubMed ID: 4203576
    [No Abstract]   [Full Text] [Related]  

  • 40. Bupropion and amitriptyline in the treatment of depressed patients.
    Chouinard G
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):121-9. PubMed ID: 6406440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.